What is OBM?
Original BioMedicals, Co., Ltd (OBM) was founded in 2011. OBM's mission is to solve
unmet medical needs by developing new chemical entities and also by creating novel
drug carriers to enhance or repurpose previously approved products. OBM's technology
is supported by two patented platforms: "Chelating-Complex Micelle" and
"Trigger Release Technology". Using these technologies, OBM greatly enhances
the efficacy and safety of already approved drugs by increasing their effective
half-life while reducing potentially adverse effects.
Mission
To Provide Platforms and Products for Bettering Global Public Health.
Vision
Using a collaborative research and professional environment, bring creative scientists
and
clinicians together to create novel formulations and innovative drug products that
will
improve the health and lives of people both locally and globally.